TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 266 filers reported holding TANDEM DIABETES CARE INC in Q2 2019. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,763,000 | +26.1% | 25,000 | 0.0% | 2.42% | +15.5% |
| Q3 2021 | $2,984,000 | +22.5% | 25,000 | 0.0% | 2.10% | +24.7% |
| Q2 2021 | $2,435,000 | +10.4% | 25,000 | 0.0% | 1.68% | -2.7% |
| Q1 2021 | $2,206,000 | -42.4% | 25,000 | -37.5% | 1.73% | -37.0% |
| Q4 2020 | $3,827,000 | -15.7% | 40,000 | 0.0% | 2.74% | -7.1% |
| Q3 2020 | $4,540,000 | -8.2% | 40,000 | -20.0% | 2.95% | -12.8% |
| Q2 2020 | $4,946,000 | +53.7% | 50,000 | 0.0% | 3.39% | +33.0% |
| Q1 2020 | $3,217,000 | +7.9% | 50,000 | 0.0% | 2.54% | +32.8% |
| Q4 2019 | $2,981,000 | -32.6% | 50,000 | -33.3% | 1.92% | -35.3% |
| Q3 2019 | $4,424,000 | -31.4% | 75,000 | -25.0% | 2.96% | -33.7% |
| Q2 2019 | $6,452,000 | +1.6% | 100,000 | 0.0% | 4.46% | -6.3% |
| Q1 2019 | $6,350,000 | +123.0% | 100,000 | +33.3% | 4.77% | +61.2% |
| Q4 2018 | $2,848,000 | – | 75,000 | – | 2.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |